Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for hand osteoarthritis
NL-OMON25343Phase 3Active, not recruiting
- Sponsor
- Maasstad Ziekenhuis
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hand osteoarthritis comparing Hydroxychloroquine with Placebo (2 arms). Primary endpoint: Pain intensity at week 24 compared to baseline. Started Sep 2010; status: active, not recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on NL-OMON25343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25343.